The molecular basis for abnormal human lung development

Biology of the Neonate

Volumn 87, Issue 3, 2005, Pages 164-177

  Groenman, Frederick ^a   Unger, Sharon ^b   Post, Martin ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cell cell signaling; Lung development; Neonatal lung disease

Indexed keywords

CLARA CELL PROTEIN; PLATELET DERIVED GROWTH FACTOR; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR GATA 6; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

CELL DIFFERENTIATION; CONGENITAL DIAPHRAGM HERNIA; CYSTIC ADENOMATOID MALFORMATION; DEVELOPMENTAL DISORDER; DIAPHRAGM HERNIA; EPITHELIUM CELL; ESOPHAGUS FISTULA; EXTRACELLULAR MATRIX; GENE EXPRESSION; HISTOLOGY; HUMAN; HYPERPLASIA; LUNG DEVELOPMENT; LUNG DYSPLASIA; MATURATION; MICROVASCULARIZATION; MORPHOGENESIS; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY SYSTEM; REVIEW; SIGNAL TRANSDUCTION; VASCULARIZATION;

AGING; ANIMALS; ANIMALS, NEWBORN; ESOPHAGUS; FETAL DEVELOPMENT; FETUS; GROWTH SUBSTANCES; HUMANS; LUNG; RESPIRATORY TRACT DISEASES; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

FISTULA;

EID: 17844374894     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000082595     Document Type: Review

References (164)

1. Burri PH: Lung development and pulmonary angiogenesis; in Gaultier C, Bourbon J, Post M (eds): Lung Development. New York, Oxford University Press, 1999, pp 122-151.
2. Hopper AF, Hart NH: Foundations of Animal Development. New York, Oxford University Press, 1985, pp 366-378.
3. Masters JR: Epithelial-mesenchymal interaction during lung development: The effect of mesenchymal mass. Dev Biol 1976;51:98-108.
4. Spooner BS, Wessells NK: Mammalian lung development: Interactions in primordium formation and bronchial morphogenesis. J Exp Zool 1970;175:445-454.
5. Warburton D, Bellusci S, Del Moral PM, Kaartinen V, Lee M, Tefft D, Shi W: Growth factor signaling in lung morphogenetic centers: Automaticity, stereotypy and symmetry. Respir Res 2003;4:5.
6. Pepicelli CV, Lewis PM, McMahon AP: Sonic hedgehog regulates branching morphogenesis in the mammalian lung. Curr Biol 1998;8:1083-1086.
7. Sekine K, Ohuchi H, Fujiwara M, Yamasaki M, Yoshizawa T, Sato T, Yagishita N, Matsui D, Koga Y, Itoh N, Kato S: Fgf10 is essential for limb and lung formation. Nat Genet 1999;21:138-141.
8. Miller LA, Wert SE, Clark JC, Xu Y, Perl AK, Whitsett JA: Role of Sonic hedgehog in patterning of tracheal-bronchial cartilage and the peripheral lung. Dev Dyn 2004;231:57-71.
9. Kaestner KH: The hepatocyte nuclear factor 3 (HNF3 or Foxa) family in metabolism. Trends Endocrinol Metab 2000;11:281-285.
10. Dufort D, Schwartz L, Harpal K, Rossant J: The transcription factor HNF3beta is required in visceral endoderm for normal primitive streak morphogenesis. Development 1998;125:3015-3025.
11. Kappen C: Hox genes in the lung. Am J Respir Cell Mol Biol 1996;15:156-162.
12. Cardoso WV: Transcription factors and pattern formation in the developing lung. Am J Physiol 1995;269:L429-L442.
13. Van Tuyl M, Post M: From fruitflies to mammals: Mechanisms of signalling via the Sonic hedgehog pathway in lung development. Respir Res 2000;1:30-35.
14. Motoyama J, Liu J, Mo R, Ding Q, Post M, Hui CC: Essential function of Gli2 and Gli3 in the formation of lung, trachea and oesophagus. Nat Genet 1998;20:54-57.
15. Bellusci S, Furuta Y, Rush MG, Henderson R, Winnier G, Hogan BL: Involvement of Sonic hedgehog (Shh) in mouse embryonic lung growth and morphogenesis. Development 1997;124:53-63.
16. Lazzaro D, Price M, de Felice M, Di Lauro R: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113:1093-1104.
17. Yuan B, Li C, Kimura S, Engelhardt RT, Smith BR, Minoo P: Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev Dyn 2000;217:180-190.
18. Meyers EN, Martin GR: Differences in left-right axis pathways in mouse and chick: Functions of FGF8 and SHH. Science 1999;285:403-406.
19. Chen J, Knowles HJ, Hebert JL, Hackett BP: Mutation of the mouse hepatocyte nuclear factor/forkhead homologue 4 gene results in an absence of cilia and random left-right asymmetry. J Clin Invest 1998;102:1077-1082.
20. Hjalt TA, Semina EV, Amendt BA, Murray JC: The Pitx2 protein in mouse development. Dev Dyn 2000;218:195-200.
21. Lin CR, Kioussi C, O'Connell S, Briata P, Szeto D, Liu F, Izpisua-Belmonte JC, Rosenfeld MG: Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature 1999;401:279-282.
22. De Moerlooze L, Spencer-Dene B, Revest J, Hajihosseini M, Rosewell I, Dickson C: An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 2000;127:483-492.
23. Peters K, Werner S, Liao X, Wert S, Whitsett J, Williams L: Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung. EMBO J 1994;13:3296-3301.
24. Guo L, Degenstein L, Fuchs E: Keratinocyte growth factor is required for hair development but not for wound healing. Genes Dev 1996;10:165-175.
25. Simonet WS, DeRose ML, Bucay N, Nguyen HQ, Wert SE, Zhou L, Ulich TR, Thomason A, Danilenko DM, Whitsett JA: Pulmonary malformation in transgenic mice expressing human keratinocyte growth factor in the lung. Proc Natl Acad Sci USA 1995;92:12461-12465.
26. Chuang PT, Kawcak T, McMahon AP: Feedback control of mammalian hedgehog signaling by the hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev 2003;17:342-347.
27. Shannon JM, Hyatt BA: Epithelial-mesenchymal interactions in the developing lung. Annu Rev Physiol 2004;66:625-645.
28. Ingham PW, McMahon AP: Hedgehog signaling in animal development: Paradigms and principles. Genes Dev 2001;15:3059-3087.
29. Spilde TL, Bhatia AM, Mehta S, Ostlie DJ, Hembree MJ, Preuett BL, Prasadan K, Li Z, Snyder CL, Gittes GK: Defective sonic hedgehog signaling in esophageal atresia with tracheoesophageal fistula. Surgery 2003;134:345-350.
30. Litingtung Y, Lei L, Westphal H, Chiang C: Sonic hedgehog is essential to foregut development. Nat Genet 1998;20:58-61.
31. Miller LA, Wert SE, Whitsett JA: Immunolocalization of sonic hedgehog (Shh) in developing mouse lung. J Histochem Cytochem 2001;49:1593-1604.
32. Minoo P, Su G, Drum H, Bringas P, Kimura S: Defects in tracheoesophageal and lung morphogenesis in Nkx2.1(-/-) mouse embryos. Dev Biol 1999;209:60-71.
33. Iwatani N, Mabe H, Devriendt K, Kodama M, Miike T: Deletion of Nkx2.1 gene encoding thyroid transcription factor-1 in two siblings with hypothyroidism and respiratory failure. J Pediatr 2000;137:272-276.
34. Devriendt K, Vanhole C, Matthijs G, de Zegher F: Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 1998;338:1317-1318.
35. Rice R, Spencer-Dene B, Connor EC, Gritli-Linde A, McMahon AP, Dickson C, Thesleff I, Rice DP: Disruption of Fgf10/Fgfr2b-coordinated epithelial-mesenchymal interactions causes cleft palate. J Clin Invest 2004;113:1692-1700.
36. Cebra-Thomas JA, Bromer J, Gardner R, Lam GK, Sheipe H, Gilbert SF: T-box gene products are required for mesenchymal induction of epithelial branching in the embryonic mouse lung. Dev Dyn 2003;226:82-90.
37. Weaver M, Dunn NR, Hogan BL: Bmp4 and Fgf10 play opposing roles during lung bud morphogenesis. Development 2000; 127:2695-2704.
38. Hiroi Y, Kudoh S, Monzen K, Ikeda Y, Yazaki Y, Nagai R, Komuro I: Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet 2001;28:276-280.
39. Xu H, Morishima M, Wylie JN, Schwartz RJ, Bruneau BG, Lindsay EA, Baldini A: Tbx1 has a dual role in the morphogenesis of the cardiac outflow tract. Development 2004;131:3217-3227.
40. Zile MH: Function of vitamin A in vertebrate embryonic development. J Nutr 2001;131:705-708.
41. Kimura Y, Suzuki T, Kaneko C, Darnel AD, Moriya T, Suzuki S, Handa M, Ebina M, Nukiwa T, Sasano H: Retinoid receptors in the developing human lung. Clin Sci (Lond) 2002;103:613-621.
42. Packer AI, Mailutha KG, Ambrozewicz LA, Wolgemuth DJ: Regulation of the Hoxa4 and Hoxa5 genes in the embryonic mouse lung by retinoic acid and TGFbetal: Implications for lung development and patterning. Dev Dyn 2000;217:62-74.
43. Golpon HA, Geraci MW, Moore MD, Miller HL, Miller GJ, Tuder RM, Voelkel NF: HOX genes in human lung: Altered expression in primary pulmonary hypertension and emphysema. Am J Pathol 2001;158:955-966.
44. Aubin J, Lemieux M, Tremblay M, Berard J, Jeannotte L: Early postnatal lethality in Hoxa-5 mutant mice is attributable to respiratory tract defects. Dev Biol 1997;192:432-445.
45. Rossel M, Capecchi MR: Mice mutant for both Hoxa1 and Hoxb1 show extensive remodeling of the hindbrain and defects in craniofacial development. Development 1999;126:5027-5040.
46. Boettger T, Wittier L, Kessel M: FGF8 functions in the specification of the right body side of the chick. Curr Biol 1999;9:277-280.
47. Garcia-Castro MI, Vielmetter E, Bronner-Fraser M: N-Cadherin, a cell adhesion molecule involved in establishment of embryonic left-right asymmetry. Science 2000;288:1047-1051.
48. Levin M: Left-right asymmetry in vertebrate embryogenesis. Bioessays 1997;19:287-296.
49. Oh SP, Li E: The signaling pathway mediated by the type IIB activin receptor controls axial patterning and lateral asymmetry in the mouse. Genes Dev 1997;11:1812-1826.
50. Hamada H, Meno C, Watanabe D, Saijoh Y: Establishment of vertebrate left-right asymmetry. Nat Rev Genet 2002;3:103-113.
51. Meno C, Shimono A, Saijoh Y, Yashiro K, Mochida K, Ohishi S, Noji S, Kondoh H, Hamada H: Lefty-1 is required for left-right determination as a regulator of lefty-2 and nodal. Cell 1998;94:287-297.
52. Schmid P, Cox D, Bilbe G, Maier R, McMaster GK: Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. Development 1991;111:117-130.
53. Zhao J, Lee M, Smith S, Warburton D: Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture. Dev Biol 1998;194:182-195.
54. Liu J, Tseu I, Wang J, Tanswell K, Post M: Transforming growth factor beta2, but not beta1 and beta3, is critical for early rat lung branching. Dev Dyn 2000;217:343-360.
55. Zhou L, Dey CR, Wert SE, Whitsett JA: Arrested lung morphogenesis in transgenic mice bearing an SP-C-TGF-beta 1 chimeric gene. Dev Biol 1996;175:227-238.
56. Keijzer R, van Tuyl M, Meijers C, Post M, Tibboel D, Grosveld F, Koutsourakis M: The transcription factor GATA6 is essential for branching morphogenesis and epithelial cell differentiation during fetal pulmonary development. Development 2001;128:503-511.
57. Koutsourakis M, Keijzer R, Visser P, Post M, Tibboel D, Grosveld F: Branching and differentiation defects in pulmonary epithelium with elevated Gata6 expression. Mech Dev 2001;105:105-114.
58. Moens CB, Stanton BR, Parada LF, Rossant J: Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. Development 1993;119:485-499.
59. De Vries JI, Visser GH, Prechtl HF: The emergence of fetal behaviour. 2. Quantitative aspects. Early Hum Dev 1985;12:99-120.
60. Harding R: Fetal pulmonary development: The role of respiratory movements. Equine Vet J Suppl 1997:32-39.
61. Tseng BS, Cavin ST, Booth FW, Olson EN, Marin MC, McDonnell TJ, Butler IJ: Pulmonary hypoplasia in the myogenin null mouse embryo. Am J Respir Cell Mol Biol 2000;22:304-315.
62. Yfantis H, Nonaka D, Castellani R, Harman C, Sun CC: Heterogeneity in fetal akinesia deformation sequence (FADS): Autopsy confirmation in three 20- to 21 -week fetuses. Prenat Diagn 2002;22:42-47.
63. Roberts AB, Mitchell J: Pulmonary hypoplasia and fetal breathing in preterm premature rupture of membranes. Early Hum Dev 1995;41:27-37.
64. Hooper SB, Han VK, Harding R: Changes in lung expansion alter pulmonary DNA synthesis and IGF-II gene expression in fetal sheep. Am J Physiol 1993;265:L403-L409.
65. Flecknoe S, Harding R, Maritz G, Hooper SB: Increased lung expansion alters the proportions of type I and type II alveolar epithelial cells in fetal sheep. Am J Physiol Lung Cell Mol Physiol 2000;278:L1180-L1185.
66. Akeson AL, Greenberg JM, Cameron JE, Thompson FY, Brooks SK, Wiginton D, Whitsett JA: Temporal and spatial regulation of VEGF-A controls vascular patterning in the embryonic lung. Dev Biol 2003;264:443-455.
67. Healy AM, Morgenthau L, Zhu X, Farber HW, Cardoso WV: VEGF is deposited in the sub-epithelial matrix at the leading edge of branching airways and stimulates neovascularization in the murine embryonic lung. Dev Dyn 2000;219:341-352.
68. Leuwerke SM, Kaza AK, Tribble CG, Kron IL, Laubach VE: Inhibition of compensatory lung growth in endothelial nitric oxide synthase-deficient mice. Am J Physiol Lung Cell Mol Physiol 2002;282:L1272-L1278.
69. Han RN, Babaei S, Robb M, Lee T, Ridsdale R, Ackerley C, Post M, Stewart DJ: Defective lung vascular development and fatal respiratory distress in endothelial NO synthase-deficient mice: A model of alveolar capillary dysplasia? Circ Res 2004;94:1115-1123.
70. 2 tension. Proc Natl Acad Sci USA 1995;92:5510-5514.
71. 2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999;15:551-578.
72. Semenza GL: HIF-1: Mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88:1474-1480.
73. 2- eregulated gene expression. FASEB J 2002;16:1151-1162.
74. Compernolle V, Brusselmans K, Franco D, Moorman A, Dewerchin M, Collen D, Carmeliet P: Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha. Cardiovasc Res 2003;60:569-579.
75. Schwarz MA, Zhang F, Gebb S, Starnes V, Warburton D: Endothelial monocyte activating polypeptide II inhibits lung neovascularization and airway epithelial morphogenesis. Mech Dev 2000;95:123-132.
76. Borges M, Linnoila RI, van de Velde HJ, Chen H, Nelkin BD, Mabry M, Baylin SB, Ball DW: An achaete-scute homologue essential for neuroendocrine differentiation in the lung. Nature 1997;386:852-855.
77. Ito T, Udaka N, Yazawa T, Okudela K, Hayashi H, Sudo T, Guillemot F, Kageyama R, Kitamura H: Basic helix-loop-helix transcription factors regulate the neuroendocrine differentiation of fetal mouse pulmonary epithelium. Development 2000;127:3913-3921.
78. Artavanis-Tsakonas S, Rand MD, Lake RJ: Notch signaling: Cell fate control and signal integration in development. Science 1999;284:770-776.
79. Kong Y, Glickman J, Subramaniam M, Shahsafaei A, Allamneni KP, Aster JC, Sklar J, Sunday ME: Functional diversity of notch family genes in fetal lung development. Am J Physiol Lung Cell Mol Physiol 2004;286:L1075-L1083.
80. Quaggin SE, Schwartz L, Cui S, Igarashi P, Deimling J, Post M, Rossant J: The basic-helix-loop-helix protein pod1 is critically important for kidney and lung organogenesis. Development 1999;126:5771-5783.
81. Bruno MD, Bohinski RJ, Huelsman KM, Whitsett JA, Korfhagen TR: Lung cell-specific expression of the murine surfactant protein A (SP-A) gene is mediated by interactions between the SP-A promoter and thyroid transcription factor-1. J Biol Chem 1995;270:6531-6536.
82. Margana RK, Boggaram V: Functional analysis of surfactant protein B (SP-B) promoter. Sp1, Sp3, TTF-1, and HNF-3alpha transcription factors are necessary for lung cell-specific activation of SP-B gene transcription. J Biol Chem 1997;272:3083-3090.
83. Kelly SE, Bachurski CJ, Burhans MS, Glasser SW: Transcription of the lung-specific surfactant protein C gene is mediated by thyroid transcription factor 1. J Biol Chem 1996;271:6881-6888.
84. Toonen RF, Gowan S, Bingle CD: The lung enriched transcription factor TTF-1 and the ubiquitously expressed proteins Sp1 and Sp3 interact with elements located in the minimal promoter of the rat Clara cell secretory protein gene. Biochem J 1996;316(pt 2):467-473.
85. Bohinski RJ, Di Lauro R, Whitsett JA: The lung-specific surfactant protein B gene promoter is a target for thyroid transcription factor 1 and hepatocyte nuclear factor 3, indicating common factors for organ-specific gene expression along the foregut axis. Mol Cell Biol 1994;14:5671-5681.
86. Bingle CD, Gitlin JD: Identification of hepatocyte nuclear factor-3 binding sites in the Clara cell secretory protein gene. Biochem J 1993;295(pt 1):227-232.
87. Liu C, Glasser SW, Wan H, Whitsett JA: GATA-6 and thyroid transcription factor-1 directly interact and regulate surfactant protein-C gene expression. J Biol Chem 2002;277:4519-4525.
88. Del Riccio V, van Tuyl M, Post M: Apoptosis in lung development and neonatal lung injury. Pediatr Res 2004;55:183-189.
89. Jaskoll T, Choy HA, Melnick M: The glucocorticoid-glucocorticoid receptor signal transduction pathway, transforming growth factor-beta, and embryonic mouse lung development in vivo. Pediatr Res 1996;39:749-759.
90. Kitraki E, Kittas C, Stylianopoulou F: Glucocorticoid receptor gene expression during rat embryogenesis. An in situ hybridization study. Differentiation 1997;62:21-31.
91. Cole TJ, Blendy JA, Monaghan AP, Krieglstein K, Schmid W, Aguzzi A, Fantuzzi G, Hummler E, Unsicker K, Schutz G: Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev 1995;9:1608-1621.
92. Kaplan F, Comber J, Sladek R, Hudson TJ, Muglia LJ, Macrae T, Gagnon S, Asada M, Brewer JA, Sweezey NB: The growth factor midkine is modulated by both glucocorticoid and retinoid in fetal lung development. Am J Respir Cell Mol Biol 2003;28:33-41.
93. Oshika E, Liu S, Singh G, Michalopoulos GK, Shinozuka H, Katyal SL: Antagonistic effects of dexamethasone and retinoic acid on rat lung morphogenesis. Pediatr Res 1998;43:315-324.
94. Sweezey NB, Ghibu F, Gagnon S, Schotman E, Hamid Q: Glucocorticoid receptor mRNA and protein in fetal rat lung in vivo: Modulation by glucocorticoid and androgen. Am J Physiol 1998;275:L103-L109.
95. Wang J, Kuliszewski M, Yee W, Sedlackova L, Xu J, Tseu I, Post M: Cloning and expression of glucocorticoid-induced genes in fetal rat lung fibroblasts. Transforming growth factor-beta 3. J Biol Chem 1995;270:2722-2728.
96. Kaartinen V, Voncken JW, Shuler C, Warburton D, Bu D, Heisterkamp N, Groffen J: Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction. Nat Genet 1995;11:415-421.
97. Boland R, Joyce BJ, Wallace MJ, Stanton H, Fosang AJ, Pierce RA, Harding R, Hooper SB: Cortisol enhances structural maturation of the hypoplastic fetal lung in sheep. J Physiol 2004;554:505-517.
98. Crowther CA, Harding J: Repeat doses of prenatal corticosteroids for women at risk of preterm birth for preventing neonatal respiratory disease. Cochrane Database Syst Rev 2003:CD003935.
99. Wan H, Kaestner KH, Ang SL, Ikegami M, Finkelman FD, Stahlman MT, Fulkerson PC, Rothenberg ME, Whitsett JA: Foxa2 regulates alveolarization and goblet cell hyperplasia. Development 2004;131:953-964.
100. Liu C, Ikegami M, Stahlman MT, Dey CR, Whitsett JA: Inhibition of alveolarization and altered pulmonary mechanics in mice expressing GATA-6. Am J Physiol Lung Cell Mol Physiol 2003;285:L1246-L1254.
101. Lindahl P, Karlsson L, Hellstrom M, Gebre-Medhin S, Willetts K, Heath JK, Betsholtz C: Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development 1997;124:3943-3953.
102. Wert SE, Dey CR, Blair PA, Kimura S, Whitsett JA: Increased expression of thyroid transcription factor-1 (TTF-1) in respiratory epithelial cells inhibits alveolarization and causes pulmonary inflammation. Dev Biol 2002;242:75-87.
103. Yang L, Naltner A, Yan C: Overexpression of dominant negative retinoic acid receptor alpha causes alveolar abnormality in transgenic neonatal lungs. Endocrinology 2003;144:3004-3011.
104. Le Cras TD, Spitzmiller RE, Albertine KH, Greenberg JM, Whitsett JA, Akeson AL: VEGF causes pulmonary hemorrhage, hemosiderosis, and air space enlargement in neonatal mice. Am J Physiol Lung Cell Mol Physiol 2004;287:L134-L142.
105. Muratore CS, Nguyen HT, Ziegler MM, Wilson JM: Stretch-induced upregulation of VEGF gene expression in murine pulmonary culture: A role for angiogenesis in lung development. J Pediatr Surg 2000;35:906-912; discussion 912-913.
106. Reynolds PR, Mucenski ML, Le Cras TD, Nichols WC, Whitsett JA: Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 2004;279:31124-31132.
107. Kalinichenko VV, Lim L, Stolz DB, Shin B, Rausa FM, Clark J, Whitsett JA, Watkins SC, Costa RH: Defects in pulmonary vasculature and perinatal lung hemorrhage in mice heterozygous null for the Forkhead Box f1 transcription factor. Dev Biol 2001;235:489-506.
108. McMullen KP, Karnes PS, Moir CR, Michels VV: Familial recurrence of tracheoesophageal fistula and associated malformations. Am J Med Genet 1996;63:525-528.
109. Pletcher BA, Friedes JS, Breg WR, Touloukian RJ: Familial occurrence of esophageal atresia with and without tracheoesophageal fistula: Report of two unusual kindreds. Am J Med Genet 1991;39:380-384.
110. Mahlapuu M, Enerback S, Carlsson P: Haploinsufficiency of the forkhead gene Foxf1, a target for sonic hedgehog signaling, causes lung and foregut malformations. Development 2001;128:2397-2406.
111. Luo J, Sucov HM, Bader JA, Evans RM, Giguere V: Compound mutants for retinoic acid receptor (RAR) beta and RAR alpha 1 reveal developmental functions for multiple RAR beta isoforms. Mech Dev 1996;55:33-44.
112. Ming JE, Roessler E, Muenke M: Human developmental disorders and the Sonic hedge-hog pathway. Mol Med Today 1998;4:343-349.
113. Kim J, Kim P, Hui CC: The VACTERL association: Lessons from the Sonic hedgehog pathway. Clin Genet 2001;59:306-315.
114. Ioannides AS, Henderson DJ, Spitz L, Copp AJ: Role of Sonic hedgehog in the development of the trachea and oesophagus. J Pediatr Surg 2003;38:29-36; discussion 29-36.
115. Spilde T, Bhatia A, Ostlie D, Marosky J, Holcomb G 3rd, Snyder C, Gittes G: A role for sonic hedgehog signaling in the pathogenesis of human tracheoesophageal fistula. J Pediatr Surg 2003;38:465-468.
116. Crisera CA, Grau JB, Maldonado TS, Kadison AS, Longaker MT, Gittes GK: Defective epithelial-mesenchymal interactions dictate the organogenesis of tracheoesophageal fistula. Pediatr Surg Int 2000;16:256-261.
117. Crisera CA, Maldonado TS, Longaker MT, Gittes GK: Defective fibroblast growth factor signaling allows for nonbranching growth of the respiratory-derived fistula tract in esophageal atresia with tracheoesophageal fistula. J Pediatr Surg 2000;35:1421-1425.
118. Spilde TL, Bhatia AM, Marosky JK, Preuett B, Kobayashi H, Hembree MJ, Prasadan K, Daume E, Snyder CL, Gittes GK: Fibroblast growth factor signaling in the developing tracheoesophageal fistula. J Pediatr Surg 2003;38:474-477; discussion 474-477.
119. Spilde TL, Bhatia AM, Miller KA, Ostlie DJ, Chaignaud BE, Holcomb GW 3rd, Snyder CL, Gittes GK: Thyroid transcription factor-1 expression in the human neonatal tracheoesophageal fistula. J Pediatr Surg 2002;37:1065-1067.
120. Babiuk RP, Greer JJ: Diaphragm defects occur in a CDH hernia model independently of myogenesis and lung formation. Am J Physiol Lung Cell Mol Physiol 2002;283:L1310-L1314.
121. Keijzer R, Liu J, Deimling J, Tibboel D, Post M: Dual-hit hypothesis explains pulmonary hypoplasia in the nitrofen model of congenital diaphragmatic hernia. Am J Pathol 2000;156:1299-1306.
122. Davenport M: Diaphragmatic hernia; in Rennie JM, Roberton NRC (eds): Textbook of Neonatology. Edinburgh, Churchill Livingstone, 1999, pp 654-661.
123. Chang R, Andreoli S, Ng YS, Truong T, Smith SR, Wilson J, D'Amore PA: VEGF expression is downregulated in nitrofen-induced congenital diaphragmatic hernia. J Pediatr Surg 2004;39:825-828; discussion 825-828.
124. Teramoto H, Yoneda A, Puri P: Gene expression of fibroblast growth factors 10 and 7 is downregulated in the lung of nitrofen-induced diaphragmatic hernia in rats. J Pediatr Surg 2003;38:1021-1024.
125. Unger S, Copland I, Tibboel D, Post M: Down-regulation of sonic hedgehog expression in pulmonary hypoplasia is associated with congenital diaphragmatic hernia. Am J Pathol 2003;162:547-555.
126. Leinwand MJ, Zhao J, Tefft JD, Anderson KD, Warburton D: Murine nitrofen-induced pulmonary hypoplasia does not involve induction of TGF-beta signaling. J Pediatr Surg 2002;37:1123-1127.
127. Miyazaki E, Ohshiro K, Taira Y, Puri P: Altered insulin-like growth factor I mRNA expression in human hypoplastic lung in congenital diaphragmatic hernia. J Pediatr Surg 1998;33:1476-1479.
128. Guarino N, Solari V, Shima H, Puri P: Upregulated expression of EGF and TGF-alpha in the proximal respiratory epithelium in the human hypoplastic lung in congenital diaphragmatic hernia. Pediatr Surg Int 2004;19:755-759.
129. Babiuk RP, Thebaud B, Greer JJ: Reductions in the incidence of nitrofen-induced diaphragmatic hernia by vitamin A and retinoic acid. Am J Physiol Lung Cell Mol Physiol 2004;286:L970-L973.
130. Greer JJ, Babiuk RP, Thebaud B: Etiology of congenital diaphragmatic hernia: The retinoid hypothesis. Pediatr Res 2003;53:726-730.
131. Chinoy MR, Nielsen HC, Volpe MV: Mesenchymal nuclear transcription factors in nitrofen-induced hypoplastic lung. J Surg Res 2002;108:203-211.
132. Solari V, Puri P: Glucocorticoid receptor gene expression in the hypoplastic lung of newborns with congenital diaphragmatic hernia. J Pediatr Surg 2002;37:715-718.
133. Losada A, Tovar JA, Xia HM, Diez-Pardo JA, Santisteban P: Down-regulation of thyroid transcription factor-1 gene expression in fetal lung hypoplasia is restored by glucocorticoids. Endocrinology 2000;141:2166-2173.
134. Hosgor M, Ijzendoorn Y, Mooi WJ, Tibboel D, De Krijger RR: Thyroid transcription factor- 1 expression during normal human lung development and in patients with congenital diaphragmatic hernia. J Pediatr Surg 2002;37:1258-1262.
135. Moessinger AC, Harding R, Adamson TM, Singh M, Kiu GT: Role of lung fluid volume in growth and maturation of the fetal sheep lung. J Clin Invest 1990;86:1270-1277.
136. Harrison MR, Sydorak RM, Farrell JA, Kitterman JA, Filly RA, Albanese CT: Fetoscopic temporary tracheal occlusion for congenital diaphragmatic hernia: Prelude to a randomized, controlled trial. J Pediatr Surg 2003;38:1012-1020.
137. Deprest J, Gratacos E, Nicolaides KH: Fetoscopic tracheal occlusion (FETO) for severe congenital diaphragmatic hernia: Evolution of a technique and preliminary results. Ultrasound Obstet Gynecol 2004;24:121-126.
138. Wu J, Ge X, Verbeken EK, Gratacos E, Yesildaglar N, Deprest JA: Pulmonary effects of in utero tracheal occlusion are dependent on gestational age in a rabbit model of diaphragmatic hernia. J Pediatr Surg 2002;37:11-17.
139. Yoshizawa J, Chapin CJ, Sbragia L, Ertsey R, Gutierrez JA, Albanese CT, Kitterman JA: Tracheal occlusion stimulates cell cycle progression and type I cell differentiation in lungs of fetal rats. Am J Physiol Lung Cell Mol Physiol 2003;285:L344-L353.
140. Nobuhara KK, DiFiore JW, Ibla JC, Siddiqui AM, Ferretti ML, Fauza DO, Schnitzer JJ, Wilson JM: Insulin-like growth factor-I gene expression in three models of accelerated lung growth. J Pediatr Surg 1998;33:1057-1060; discussion 1061.
141. McCabe AJ, Carlino U, Holm BA, Glick PL: Upregulation of keratinocyte growth factor in the tracheal ligation lamb model of congenital diaphragmatic hernia. J Pediatr Surg 2001;36:128-132.
142. Quinn TM, Sylvester KG, Kitano Y, Liechty KW, Jarrett BP, Adzick NS, Flake AW: TGF-beta2 is increased after fetal tracheal occlusion. J Pediatr Surg 1999;34:701-704; discussion 704-705.
143. Heerema AE, Rabban JT, Sydorak RM, Harrison MR, Jones KD: Lung pathology in patients with congenital diaphragmatic hernia treated with fetal surgical intervention, including tracheal occlusion. Pediatr Dev Pathol 2003;6:536-546.
144. Bin Saddiq W, Piedboeuf B, Laberge JM, Gamache M, Petrov P, Hashim E, Manika A, Chen MF, Belanger S, Piuze G: The effects of tracheal occlusion and release on type II pneumocytes in fetal lambs. J Pediatr Surg 1997;32:834-838.
145. Kay S, Laberge JM, Flageole H, Richardson S, Belanger S, Piedboeuf B: Use of antenatal steroids to counteract the negative effects of tracheal occlusion in the fetal lamb model. Pediatr Res 2001;50:495-501.
146. Steinhorn RH, Cox PN, Fineman JR, Finer NN, Rosenberg EM, Silver MM, Tyebkhan J, Zwass MS, Morin FC 3rd: Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia. J Pediatr 1997;130:417-422.
147. Janney CG, Askin FB, Kuhn C 3rd: Congenital alveolar capillary dysplasia - An unusual cause of respiratory distress in the newborn. Am J Clin Pathol 1981;76:722-727.
148. Gutierrez C, Rodriguez A, Palenzuela S, Forteza C, Rossello JL: Congenital misalignment of pulmonary veins with alveolar capillary dysplasia causing persistent neonatal pulmonary hypertension: Report of two affected siblings. Pediatr Dev Pathol 2000;3:271-276.
149. Zhang R, Wang L, Zhang L, Chen J, Zhu Z, Zhang Z, Chopp M: Nitric oxide enhances angiogenesis via the synthesis of vascular endothelial growth factor and cGMP after stroke in the rat. Circ Res 2003;92:308-313.
150. Volpe MV, Pham L, Lessin M, Ralston SJ, Bhan I, Cutz E, Nielsen HC: Expression of HoxbS during human lung development and in congenital lung malformations. Birth Defects Res Part A Clin Mol Teratol 2003;67:550-556.
151. Morotti RA, Cangiarella J, Gutierrez MC, Jagirdar J, Askin F, Singh G, Profitt SA, Wert SE, Whitsett JA, Greco MA: Congenital cystic adenomatoid malformation of the lung (CCAM): Evaluation of the cellular components. Hum Pathol 1999;30:618-625.
152. Northway WH Jr, Rosan RC, Porter DY: Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 1967;276:357-368.
153. Bhandari A, Bhandari V: Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci 2003;8:e370-e380.
154. Abman SH: Bronchopulmonary dysplasia: 'A vascular hypothesis'. Am J Respir Crit Care Med 2001;164:1755-1756.
155. Gerber HP, Hillan KJ, Ryan AM, Kowalski J, Keller GA, Rangell L, Wright BD, Radtke F, Aguet M, Ferrara N: VEGF is required for growth and survival in neonatal mice. Development 1999;126:1149-1159.
156. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK, Waltenberger J, Voelkel NF: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000;106:1311-1319.
157. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH: Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 2002;283:L555-L562.
158. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM: Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;164:1971-1980.
159. Lassus P, Turanlahti M, Heikkila P, Andersson LC, Nupponen I, Sarnesto A, Andersson S: Pulmonary vascular endothelial growth factor and Flt-1 in fetuses, in acute and chronic lung disease, and in persistent pulmonary hypertension of the newborn. Am J Respir Crit Care Med 2001;164:1981-1987.
160. Kotch LE, Iyer NV, Laughner E, Semenza GL: Defective vascularization of HIF-1alpha-null embryos is not associated with VEGF deficiency but with mesenchymal cell death. Dev Biol 1999;209:254-267.
161. Compernolle V, Brusselmans K, Acker T, Hoet P, Tjwa M, Beck H, Plaisance S, Dor Y, Keshet E, Lupu F, Nemery B, Dewerchin M, Van Veldhoven P, Plate K, Moons L, Collen D, Carmeliet P: Loss of HIF-2alpha and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002;8:702-710.
162. Brown KR, England KM, Goss KL, Snyder JM, Acarregui MJ: VEGF induces airway epithelial cell proliferation in human fetal lung in vitro. Am J Physiol Lung Cell Mol Physiol 2001;281:L1001-L1010.
163. O'Shea TM, Doyle LW: Perinatal glucocorticoid therapy and neurodevelopmental outcome: An epidemiologic perspective. Semin Neonatol 2001;6:293-307.
164. Jankov RP, Keith Tanswell A: Growth factors, postnatal lung growth and bronchopulmonary dysplasia. Paediatr Respir Rev 2004;5(supplA):S265-S275.